title: Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.
abstract: Nemaline myopathy (NM), the most common non-dystrophic congenital disease of skeletal muscle, can be caused by mutations in the skeletal muscle α-actin gene (ACTA1) (~25% of all NM cases and up to 50% of severe forms of NM). Muscle function of the recently generated transgenic mouse model carrying the human Asp286Gly mutation in the ACTA1 gene (Tg(ACTA1)(Asp286Gly)) has been mainly investigated in vitro. Therefore, we aimed at providing a comprehensive picture of the in vivo hindlimb muscle function of Tg(ACTA1)(Asp286Gly) mice by combining strictly noninvasive investigations. Skeletal muscle anatomy (hindlimb muscles, intramuscular fat volumes) and microstructure were studied using multimodal magnetic resonance imaging (Dixon, T2, Diffusion Tensor Imaging [DTI]). Energy metabolism was studied using 31-phosphorus Magnetic Resonance Spectroscopy ((31)P-MRS). Skeletal muscle contractile performance was investigated while applying a force-frequency protocol (1-150 Hz) and a fatigue protocol (6 min-1.7 Hz). Tg(ACTA1)(Asp286Gly) mice showed a mild muscle weakness as illustrated by the reduction of both absolute (30%) and specific (15%) maximal force production. Dixon MRI did not show discernable fatty infiltration in Tg(ACTA1)(Asp286Gly) mice indicating that this mouse model does not reproduce human MRI findings. Increased T2 values were observed in Tg(ACTA1)(Asp286Gly) mice and might reflect the occurrence of muscle degeneration/regeneration process. Interestingly, T2 values were linearly related to muscle weakness. DTI experiments indicated lower λ2 and λ3 values in Tg(ACTA1)(Asp286Gly) mice, which might be associated to muscle atrophy and/or the presence of histological anomalies. Finally (31)P-MRS investigations illustrated an increased anaerobic energy cost of contraction in Tg(ACTA1)(Asp286Gly) mice, which might be ascribed to contractile and non-contractile processes. Overall, we provide a unique set of information about the anatomic, metabolic and functional consequences of the Asp286Gly mutation that might be considered as relevant biomarkers for monitoring the severity and/or the progression of NM and for assessing the efficacy of potential therapeutic interventions.
authors: Aix-Marseille Université, Centre National de la Recherche Scientifique, Centre de Résonance Magnétique Biologique et Médicale, Unité Mixte de Recherche 7339, Marseille, France.
authors: Charlotte
authors: C
authors: Gineste
authors: Guillaume
authors: G
authors: Duhamel
authors: Yann
authors: Y
authors: Le Fur
authors: Christophe
authors: C
authors: Vilmen
authors: Patrick J
authors: PJ
authors: Cozzone
authors: Kristen J
authors: KJ
authors: Nowak
authors: David
authors: D
authors: Bendahan
authors: Julien
authors: J
authors: Gondin
mesh_terms: D000199:Actins / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D004734:Energy Metabolism; D015870:Gene Expression; D006614:Hindlimb; D006801:Humans; D008279:Magnetic Resonance Imaging; D051379:Mice; D008822:Mice, Transgenic; D064847:Multimodal Imaging; D009119:Muscle Contraction; D018763:Muscle Fatigue; D018908:Muscle Weakness / Q000378:metabolism / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000378:metabolism / Q000503:physiopathology*; D009133:Muscular Atrophy / Q000378:metabolism / Q000503:physiopathology*; D009154:Mutation; D017696:Myopathies, Nemaline / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D010641:Phenotype
chemical_list: D000199:Actins
references: Acta Radiol. 1994 Mar;35(2):96-116
references: 8172753
references: Adv Exp Med Biol. 2008;642:66-77
references: 19181094
references: Neuromuscul Disord. 2004 Sep;14(8-9):461-70
references: 15336686
references: Neurology. 2003 Feb 25;60(4):665-73
references: 12601110
references: Skeletal Radiol. 2012 Apr;41(4):437-45
references: 21800026
references: J Biol Chem. 1973 Oct 25;248(20):7276-8
references: 4743524
references: PLoS One. 2011;6(12):e28699
references: 22174871
references: Neuromuscul Disord. 2002 Mar;12(3):247-57
references: 11801396
references: Annu Rev Physiol. 1978;40:93-131
references: 345955
references: Semin Pediatr Neurol. 2011 Dec;18(4):221-9
references: 22172417
references: Hum Mol Genet. 2011 May 15;20(10):2015-25
references: 21357678
references: Hum Mol Genet. 2001 Feb 15;10(4):317-28
references: 11157795
references: Acta Neuropathol. 2012 May;123(5):739-46
references: 22358459
references: Muscle Nerve. 1985 May;8(4):299-306
references: 16758596
references: J Magn Reson Imaging. 2011 Jan;33(1):203-10
references: 21182140
references: PLoS One. 2013 Apr 16;8(4):e61517
references: 23613869
references: MAGMA. 2006 Nov;19(5):275-9
references: 17004065
references: Muscle Nerve. 2011 Jun;43(6):878-86
references: 21488051
references: J Appl Physiol (1985). 2008 Jul;105(1):299-307
references: 18450983
references: Mol Cell Biol. 2002 Aug;22(16):5887-96
references: 12138199
references: PLoS One. 2012;7(9):e45923
references: 23029319
references: Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4666-71
references: 12677001
references: J Neurol. 2011 Jul;258(7):1333-40
references: 21340522
references: Neuromuscul Disord. 2004 Mar;14(3):208-16
references: 15036331
references: AJR Am J Roentgenol. 2008 Jan;190(1):W8-12
references: 18094282
references: J Pathol. 2005 Nov;207(3):313-23
references: 16178054
references: Ann Neurol. 2004 Jul;56(1):86-96
references: 15236405
references: Neuromuscul Disord. 2000 Jun;10(4-5):307-12
references: 10838259
references: Magn Reson Med. 2010 Jul;64(1):262-70
references: 20572140
references: Exp Neurol. 2008 Aug;212(2):448-57
references: 18571650
references: Radiology. 2007 May;243(2):413-21
references: 17384238
references: Am J Hum Genet. 2013 Feb 7;92(2):271-8
references: 23332920
references: MAGMA. 2010 Feb;23(1):23-30
references: 20052517
references: Neuromuscul Disord. 2010 Feb;20(2):98-101
references: 20006502
references: Magn Reson Med. 2005 Dec;54(6):1369-76
references: 16261578
references: FASEB J. 2009 Dec;23(12):4117-25
references: 19679637
references: FASEB J. 2008 Aug;22(8):2912-9
references: 18434434
references: J Cell Biol. 2006 Jun 19;173(6):905-16
references: 16769824
references: Eur J Hum Genet. 2012 Jun;20(6):
references: 22510848
references: J Med Genet. 1997 Sep;34(9):705-13
references: 9321754
references: Neuromuscul Disord. 2013 Apr;23(4):357-69
references: 23375831
references: J Child Neurol. 2012 Mar;27(3):363-82
references: 22431881
references: Neuromuscul Disord. 2004 Dec;14(12):779-84
references: 15564032
references: J Neurol. 2010 Apr;257(4):658-60
references: 20012312
references: Brain. 2002 Jul;125(Pt 7):1635-45
references: 12077012
references: Am J Physiol. 1998 Mar;274(3):E397-402
references: 9530120
references: Phys Med Rehabil Clin N Am. 2012 Feb;23(1):1-10, ix
references: 22239869
references: Radiology. 2010 Jun;255(3):899-908
references: 20501727
references: Brain. 2011 Dec;134(Pt 12):3516-29
references: 22067542
references: Brain. 2011 Apr;134(Pt 4):1101-15
references: 21303860
references: Cell Mol Life Sci. 2004 May;61(9):1001-15
references: 15112049